Syndax Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SNDX and other ETFs, options, and stocks.

About SNDX

Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include SyndAccess, Revuforj, Niktimvo, and IncyteCARES. 

CEO
Michael A. Metzger
CEOMichael A. Metzger
Employees
270
Employees270
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
2005
Founded2005
Employees
270
Employees270

SNDX Key Statistics

Market cap
1.38B
Market cap1.38B
Price-Earnings ratio
-4.15
Price-Earnings ratio-4.15
Dividend yield
—
Dividend yield—
Average volume
2.06M
Average volume2.06M
High today
$16.48
High today$16.48
Low today
$15.41
Low today$15.41
Open price
$16.28
Open price$16.28
Volume
2.00M
Volume2.00M
52 Week high
$22.50
52 Week high$22.50
52 Week low
$8.58
52 Week low$8.58

Analyst ratings

100%

of 13 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own SNDX. This list is generated using Robinhood data, and it’s not a recommendation.
Pfizer
Viking Therapeutics
Plug Power
Moderna
Tilray Brands
Micron Technology
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.